UK Markets close in 6 hrs 44 mins

Inhibikase Therapeutics, Inc. (IKT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6585+0.0565 (+9.39%)
At close: 03:59PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts0011
Avg. Estimate00-0.74-0.68
Low estimate00-0.74-0.68
High estimate00-0.74-0.68
Year ago EPS-0.2-0.18-0.81-0.74
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1011
Avg. EstimateN/AN/A100kN/A
Low estimateN/AN/A100kN/A
High estimateN/AN/A100kN/A
Year ago sales2kN/A3.1M100k
Sales growth (year/est)N/AN/A-96.80%N/A
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.17-0.17-0.19-0.18
Actual EPS-0.2-0.18-0.18-0.18
Difference-0.03-0.010.010
Surprise %-17.60%-5.90%5.30%0.00%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate00-0.74-0.68
7 days ago-0.190-0.74-0.68
30 days ago-0.190-0.74-0.68
60 days ago-0.190-0.74-0.68
90 days ago-0.190-0.73-0.69
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesIKTIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year8.60%N/AN/AN/A
Next year8.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A